Skip to content
Search

Latest Stories

UK has reached 200,000 capacity testing target: Government

Britain has reached its 200,000 capacity testing target for the coronavirus, including the means for 40,000 antibody tests a day, the government said on Sunday (May 31), adding that it had met the goal a day early.

The UK’s death toll from people who have tested positive for Covid-19 has risen by 113 to 38,489, the government said on Sunday.


Prime minister Boris Johnson set the target of reaching 200,000 tests a day by the end of the month, with aides later saying it was an operational target for Britain to have the capacity to do that number of tests.

"Reaching our 200,000 capacity target is an important milestone on our journey to control the spread of the virus, save lives and gradually ease lockdown," health minister Matt Hancock said in a statement.

"By rapidly expanding our testing capacity, we have been able to introduce NHS (National Health Service) Test and Trace, and enabling those who have coronavirus symptoms to get a test is an important part of the programme."

(Reuters)

More For You

national prescribing service for pharmacists

Sadik Al-Hassan MP

Sadik-Al-Hassan: National pharmacy prescribing service “entirely possible”

A national prescribing service for pharmacists could in theory be developed in the next two-three years according to Sadik-Al-Hassan MP.

Speaking at an event organised by PharmaTech in parliament on Wednesday, Hassan said community pharmacists had the skillset to prescribe but a national service would be “limited” by what they are currently allowed to do.

Keep ReadingShow less
First daily pill for endometriosis to be available on NHS

Instead of travelling to clinics for injections, endometriosis patients can take a daily tablet at home

Getty Images

New endometriosis pill approved for NHS use, but only few patients will benefit

The National Institute for Health and Care Excellence (NICE) has approved a new pill for the treatment of endometriosis, providing hope for thousands of women affected by the debilitating condition.

The pill, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), is the first long-term daily pill approved for use in the UK to treat endometriosis, and it is expected to help about 1,000 patients every year.

Keep ReadingShow less
​RPS urges its members and fellows to vote in favour of Royal College for “a stronger, louder voice”

The Special Resolution Vote will remain open until 5 p.m. on Thursday, 24 March 2025.

Getty Images

Royal College voting begins: A historic moment in the profession’s evolution

Becoming a royal college will ensure pharmacy profession gains the recognition and authority it deserves, says RPS president Professor Claire Anderson.

Starting today (13), members and fellows of the Royal Pharmaceutical Society (RPS) will begin voting on the proposed changes to its Royal Charter, marking the beginning of a historic shift toward becoming the Royal College of Pharmacy.

Keep ReadingShow less
GPs to play crucial role in transforming Wales’ health service

Jeremy Miles

(Photo credit: www.gov.wales )

Strengthening GPs’ role key to transforming healthcare - Jeremy Miles

Welsh health secretary Jeremy Miles has recognised the need to transform health services and bring healthcare closer to home.

Speaking at the recent Welsh Local Medical Committees Conference, he emphasised that strengthening the role of GPs would be crucial in improving patient healthcare and tackling NHS waiting lists.

Keep ReadingShow less